VYNE Therapeutics
VYNE
#10596
Rank
โ‚น1.64 B
Marketcap
โ‚น49.15
Share price
-44.88%
Change (1 day)
-61.06%
Change (1 year)

VYNE Therapeutics (VYNE) - Total assets

Total assets on the balance sheet as of March 2026 : โ‚น2.49 Billion

According to VYNE Therapeutics's latest financial reports the company's total assets are โ‚น2.49 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

VYNE Therapeutics - Total assets on balance sheet (from 2016 to 2026)

Total assets by year

Year Total assets Change
2025-12-31โ‚น2.70 B-52.83%
2024-12-31โ‚น5.73 B-29.42%
2023-12-31โ‚น8.13 B141.12%
2022-12-31โ‚น3.37 B-32.41%
2021-12-31โ‚น4.99 B-27.21%
2020-12-31โ‚น6.85 B21.43%
2019-12-31โ‚น5.64 B-42.3%
2018-12-31โ‚น9.78 B129.16%
2017-12-31โ‚น4.26 B49.4%
2016-12-31โ‚น2.85 B-2.01%
2015-12-31โ‚น2.91 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น42.17 B 1,588.10%๐Ÿ‡บ๐Ÿ‡ธ USA